Defiance Daily Target 2X Long HIMS ETF (HIMZ) Analysis: Leveraged Bet on Telehealth Momentum
Key Takeaways
- Defiance Daily Target 2X Long HIMS ETF (HIMZ) is a leveraged exchange-traded fund (ETF) designed to deliver two times (200%) the daily percentage change in the share price of Hims & Hers Health Inc. (HIMS).
- The fund employs derivatives to achieve its leveraged exposure and resets daily, making it suitable for short-term trading rather than long-term buy-and-hold strategies.
- HIMZ provides targeted access to the telehealth and consumer health sector through a single-stock focus on HIMS, with an expense ratio of 1.29%.
- As a non-diversified, actively managed leveraged product, it carries amplified volatility and is subject to compounding effects over multiple days.
- Key risks include leverage decay, high expense ratio relative to unleveraged peers, and concentration in one underlying equity.
Defiance Daily Target 2X Long HIMS ETF (HIMZ) Overview
The Defiance Daily Target 2X Long HIMS ETF (HIMZ) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Hims & Hers Health Inc. (HIMS), before fees and expenses. Launched on March 12, 2025, by Defiance ETFs, the fund is structured as a non-diversified, actively managed ETF that uses swaps, futures, and other derivatives to obtain its target exposure rather than holding the underlying shares directly.
Because it is a single-asset leveraged product, HIMZ does not maintain a traditional portfolio of multiple holdings or sector allocations beyond its 100% linkage to HIMS. The expense ratio stands at 1.29%. The fund trades on the Nasdaq and resets its leverage target each trading day, which distinguishes it from traditional passive or multi-asset thematic ETFs.
Industry and Thematic Landscape
HIMZ provides leveraged exposure to the telehealth and digital health sector, centered on Hims & Hers Health Inc. (HIMS), a company focused on personalized telehealth services for men’s and women’s health, including hair loss, sexual health, and weight management treatments. Structural growth drivers in this space include rising consumer adoption of convenient virtual care platforms, ongoing innovation in personalized medicine, and expanding insurance coverage for certain telehealth services.
Macroeconomic factors such as interest rate expectations, healthcare spending trends, and regulatory developments around digital health platforms influence the sector. Capital flows into consumer health technology have accelerated in recent years, supported by demographic shifts toward younger patients seeking accessible care. Potential risks include reimbursement policy changes, increased competition from traditional healthcare providers, and shifts in consumer spending patterns during economic uncertainty.
Performance and Positioning Snapshot
In recent market cycles, HIMZ has exhibited significant volatility consistent with its leveraged structure and the underlying movement of HIMS. The ETF’s daily reset mechanism amplifies both gains and losses, leading to pronounced reactions during earnings seasons for HIMS and broader sector rotation into healthcare technology names.
Performance has been influenced by catalysts such as quarterly results from HIMS, evolving expectations around interest rates, and capital allocation trends within the consumer discretionary and healthcare sectors. Over multiple-week periods, the fund’s behavior reflects the compounded impact of daily leverage rather than a simple linear multiple of the underlying stock’s return.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. AI Screener
2026 Outlook and Key Factors to Monitor
Looking ahead to 2026, structural drivers for the telehealth space include continued expansion of digital health infrastructure, potential regulatory clarity on virtual care reimbursement, and ongoing product innovation by companies such as HIMS. Macro risks to monitor encompass shifts in monetary policy that could affect growth-oriented sectors, changes in healthcare legislation, and competitive pressures within the consumer health market.
Investors should also consider the impact of the ETF’s expense ratio on longer-term holding periods and the effects of daily leverage reset on returns during periods of elevated volatility. The broader competitive ETF landscape features both unleveraged thematic healthcare funds and other single-stock leveraged products, which may influence relative flows. Earnings cycles of HIMS and capital allocation trends across digital health will remain important variables shaping sector performance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Momentum Indicator for HIMZ turns positive, indicating new upward trend
HIMZ saw its Momentum Indicator move above the 0 level on May 28, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator turned positive. In of the 14 cases, the stock moved higher in the following days. The odds of a move higher are at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for HIMZ just turned positive on May 29, 2026. Looking at past instances where HIMZ's MACD turned positive, the stock continued to rise in of 9 cases over the following month. The odds of a continued upward trend are .
HIMZ moved above its 50-day moving average on June 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HIMZ crossed bullishly above the 50-day moving average on June 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where HIMZ advanced for three days, in of 57 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 25 cases where HIMZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for HIMZ moved out of overbought territory on June 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 4 similar instances where the indicator moved out of overbought territory. In of the 4 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
HIMZ broke above its upper Bollinger Band on June 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.